Interferon-γ and interleukin 22 act synergistically for the induction of interferon-stimulated genes and control of rotavirus infection

Nature Immunology

Volumn 16, Issue 7, 2015, Pages 698-707

  Hernández, Pedro P ^a,b,c   Mahlakõiv, Tanel ^b,d   Yang, Ines ^e,f   Schwierzeck, Vera ^a,b   Nguyen, Nam ^b   Guendel, Fabian ^a,b,g   Gronke, Konrad ^a,b,c,g   Ryffel, Bernhard ^h,i,j   Hölscher, Christoph ^k,l   Dumoutier, Laure ^m   Renauld, Jean Christophe ^m   Suerbaum, Sebastian ^e,f   Staeheli, Peter ^b   Diefenbach, Andreas ^a,b,g  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

^f Center for Experimental and Clinical Infection Research   (Germany)

^g Research Training Group (GRK1104) of Organogenesis   (Germany)

^h UNIVERSITÉ D'ORLÉANS   (France)

ⁱ CNRS   (France)

^j UNIVERSITY OF CAPE TOWN   (South Africa)

^k RESEARCH CENTER BORSTEL   (Germany)

^l Cluster of Excellence Inflammation at Interfaces   (Germany)

^m UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; INTERFERON LAMBDA; INTERFERON REGULATORY FACTOR; INTERLEUKIN 22; STAT1 PROTEIN; UNCLASSIFIED DRUG; CYTOKINE; CYTOKINE RECEPTOR; INTERFERON-LAMBDA PROTEIN, MOUSE; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE INDUCTION; HUMAN; HUMAN CELL; IMMUNOGENETICS; INTESTINE EPITHELIUM CELL; LYMPHOID CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; ROTAVIRUS INFECTION; VIRUS IMMUNITY; ANIMAL; C57BL MOUSE; CACO 2 CELL LINE; CELL LINE; CHLOROCEBUS AETHIOPS; DOG; DRUG EFFECTS; DRUG POTENTIATION; EPITHELIUM CELL; GENE EXPRESSION; GENETICS; HT 29 CELL LINE; IMMUNOBLOTTING; IMMUNOLOGY; INTESTINE; KNOCKOUT MOUSE; MDCK CELL LINE; METABOLISM; MOLECULAR GENETICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; VERO CELL LINE; VIROLOGY;

ANIMALS; CACO-2 CELLS; CELL LINE; CERCOPITHECUS AETHIOPS; CYTOKINES; DOGS; DRUG SYNERGISM; EPITHELIAL CELLS; GENE EXPRESSION; HT29 CELLS; HUMANS; IMMUNOBLOTTING; INTERLEUKINS; INTESTINES; MADIN DARBY CANINE KIDNEY CELLS; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; RECEPTORS, CYTOKINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ROTAVIRUS INFECTIONS; STAT1 TRANSCRIPTION FACTOR; VERO CELLS;

EID: 84931569282     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.3180     Document Type: Article

References (69)

1. Moon, C. & Stappenbeck, T.S. Viral interactions with the host and microbiota in the intestine. Curr. Opin. Immunol. 24, 405-410 (2012).
2. Duerkop, B.A. & Hooper, L.V. Resident viruses and their interactions with the immune system. Nat. Immunol. 14, 654-659 (2013).
3. Katze, M.G., He, Y. & Gale, M. Jr. Viruses and interferon: A fight for supremacy. Nat. Rev. Immunol. 2, 675-687 (2002).
4. Durbin, R.K., Kotenko, S.V. & Durbin, J.E. Interferon induction and function at the mucosal surface. Immunol. Rev. 255, 25-39 (2013).
5. Kotenko, S.V. et al. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 4, 69-77 (2003).
6. Sheppard, P. et al. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol. 4, 63-68 (2003).
7. Dumoutier, L. et al. Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-λ1: similarities with type I interferon signaling. J. Biol. Chem. 279, 32269-32274 (2004).
8. Ank, N. et al. Lambda interferon (IFN-λ), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J. Virol. 80, 4501-4509 (2006).
9. Doyle, S.E. et al. Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes. Hepatology 44, 896-906 (2006).
10. Sadler, A.J. & Williams, B.R. Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 8, 559-568 (2008).
11. Kotenko, S.V. IFN-lambdas. Curr. Opin. Immunol. 23, 583-590 (2011).
12. Wolk, K. et al. IL-22 increases the innate immunity of tissues. Immunity 21, 241-254 (2004).
13. Sommereyns, C., Paul, S., Staeheli, P. & Michiels, T. IFN-lambda (IFN-λ) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog. 4, e1000017 (2008).
14. Rutz, S. & Ouyang, W. Regulation of interleukin-10 and interleukin-22 expression in T helper cells. Curr. Opin. Immunol. 23, 605-612 (2011).
15. Zheng, Y. et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 14, 282-289 (2008).
16. Pickert, G. et al. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J. Exp. Med. 206, 1465-1472 (2009).
17. Ramig, R.F. Pathogenesis of intestinal and systemic rotavirus infection. J. Virol. 78, 10213-10220 (2004).
18. Sen, A., Rott, L., Phan, N., Mukherjee, G. & Greenberg, H.B. Rotavirus NSP1 protein inhibits interferon-mediated STAT1 activation. J. Virol. 88, 41-53 (2014).
19. Holloway, G. & Coulson, B.S. Innate cellular responses to rotavirus infection. J. Gen. Virol. 94, 1151-1160 (2013).
20. Arnold, M.M., Sen, A., Greenberg, H.B. & Patton, J.T. The battle between rotavirus and its host for control of the interferon signaling pathway. PLoS Pathog. 9, e1003064 (2013).
21. Pott, J. et al. IFN-λ determines the intestinal epithelial antiviral host defense. Proc. Natl. Acad. Sci. USA 108, 7944-7949 (2011).
22. Feng, N. et al. Role of interferon in homologous and heterologous rotavirus infection in the intestines and extraintestinal organs of suckling mice. J. Virol. 82, 7578-7590 (2008).
23. Sen, A. et al. Innate immune response to homologous rotavirus infection in the small intestinal villous epithelium at single-cell resolution. Proc. Natl. Acad. Sci. USA 109, 20667-20672 (2012).
24. Kumar, P., Thakar, M.S., Ouyang, W. & Malarkannan, S. IL-22 from conventional NK cells is epithelial regenerative and inflammation protective during influenza infection. Mucosal Immunol. 6, 69-82 (2013).
25. Ubeda, C. et al. Familial transmission rather than defective innate immunity shapes the distinct intestinal microbiota of TLR-deficient mice. J. Exp. Med. 209, 1445-1456 (2012).
26. Zenewicz, L.A. et al. IL-22 deficiency alters colonic microbiota to be transmissible and colitogenic. J. Immunol. 190, 5306-5312 (2013).
27. Lauterbach, H. et al. Mouse CD8alpha+ DCs and human BDCA3+ DCs are major producers of IFN-lambda in response to poly IC. J. Exp. Med. 207, 2703-2717 (2010).
28. Yin, Z. et al. Type III IFNs are produced by and stimulate human plasmacytoid dendritic cells. J. Immunol. 189, 2735-2745 (2012).
29. Sanos, S.L. et al. RORγt and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nat. Immunol. 10, 83-91 (2009).
30. Liang, S.C. et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203, 2271-2279 (2006).
31. Martin, B., Hirota, K., Cua, D.J., Stockinger, B. & Veldhoen, M. Interleukin-17-producing γΔ T cells selectively expand in response to pathogen products and environmental signals. Immunity 31, 321-330 (2009).
32. Zindl, C.L. et al. IL-22-producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis. Proc. Natl. Acad. Sci. USA 110, 12768-12773 (2013).
33. Klose, C.S. et al. A T-bet gradient controls the fate and function of CCR6-RORγt+ innate lymphoid cells. Nature 494, 261-265 (2013).
34. Kiss, E.A. et al. Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science 334, 1561-1565 (2011).
35. Eberl, G. et al. An essential function for the nuclear receptor RORγ(t) in the generation of fetal lymphoid tissue inducer cells. Nat. Immunol. 5, 64-73 (2004).
36. Franco, M.A. & Greenberg, H.B. Immunity to rotavirus infection in mice. J. Infect. Dis. 179 (suppl. 3), S466-S469 (1999).
37. Kinnebrew, M.A. et al. Interleukin 23 production by intestinal CD103+CD11b+ dendritic cells in response to bacterial flagellin enhances mucosal innate immune defense. Immunity 36, 276-287 (2012).
38. Reynders, A. et al. Identity, regulation and in vivo function of gut NKp46+RORγt+ and NKp46+RORγt-lymphoid cells. EMBO J. 30, 2934-2947 (2011).
39. Schoggins, J.W. & Rice, C.M. Interferon-stimulated genes and their antiviral effector functions. Curr. Opin. Virol. 1, 519-525 (2011).
40. Bachmann, M., Ulziibat, S., Hardle, L., Pfeilschifter, J. & Muhl, H. IFNα converts IL-22 into a cytokine efficiently activating STAT1 and its downstream targets. Biochem. Pharmacol. 85, 396-403 (2013).
41. Lejeune, D. et al. Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. J. Biol. Chem. 277, 33676-33682 (2002).
42. Dai, X. et al. SOCS1-negative feedback of STAT1 activation is a key pathway in the dsRNA-induced innate immune response of human keratinocytes. J. Invest. Dermatol. 126, 1574-1581 (2006).
43. Angel, J., Franco, M.A., Greenberg, H.B. & Bass, D. Lack of a role for type I and type II interferons in the resolution of rotavirus-induced diarrhea and infection in mice. J. Interferon Cytokine Res. 19, 655-659 (1999).
44. Nice, T.J. et al. Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity. Science 347, 269-273 (2015).
45. Baldridge, M.T. et al. Commensal microbes and interferon-λ determine persistence of enteric murine norovirus infection. Science 347, 266-269 (2015).
46. Muñoz, M. et al. Interleukin-22 induces interleukin-18 expression from epithelial cells during intestinal infection. Immunity 42, 321-331 (2015).
47. Aujla, S.J. et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat. Med. 14, 275-281 (2008).
48. Dudakov, J.A. et al. Interleukin-22 drives endogenous thymic regeneration in mice. Science 336, 91-95 (2012).
49. Hanash, A.M. et al. Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease. Immunity 37, 339-350 (2012).
50. Zhang, B. et al. Viral infection. Prevention and cure of rotavirus infection via TLR5/NLRC4-mediated production of IL-22 and IL-18. Science 346, 861-865 (2014).
51. Mombaerts, P. et al. Mutations in T-cell antigen receptor genes α and β block thymocyte development at different stages. Nature 360, 225-231 (1992).
52. Itohara, S. et al. T cell receptor Δ gene mutant mice: independent generation of αβ T cells and programmed rearrangements of γΔ TCR genes. Cell 72, 337-348 (1993).
53. Alonzi, T. et al. Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation [correction of activation] in the liver. Mol. Cell. Biol. 21, 1621-1632 (2001).
54. el Marjou, F. et al. Tissue-specific and inducible Cre-mediated recombination in the gut epithelium. Genesis 39, 186-193 (2004).
55. Kreymborg, K. et al. IL-22 is expressed by Th17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitis. J. Immunol. 179, 8098-8104 (2007).
56. Ank, N. et al. An important role for type III interferon (IFN-λ/IL-28) in TLR-induced antiviral activity. J. Immunol. 180, 2474-2485 (2008).
57. Durbin, J.E., Hackenmiller, R., Simon, M.C. & Levy, D.E. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84, 443-450 (1996).
58. Eberl, G. & Littman, D.R. Thymic origin of intestinal αβ T cells revealed by fate mapping of RORγt+ cells. Science 305, 248-251 (2004).
59. Glaccum, M.B. et al. Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. J. Immunol. 159, 3364-3371 (1997).
60. Ghilardi, N. et al. Compromised humoral and delayed-type hypersensitivity responses in IL-23-deficient mice. J. Immunol. 172, 2827-2833 (2004).
61. Sanos, S.L. & Diefenbach, A. Isolation of NK cells and NK-like cells from the intestinal lamina propria. Methods Mol. Biol. 612, 505-517 (2010).
62. Yang, I. et al. Intestinal microbiota composition of interleukin-10 deficient C57BL/6J mice and susceptibility to Helicobacter hepaticus-induced colitis. PLoS ONE 8, e70783 (2013).
63. Edgar, R.C. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat. Methods 10, 996-998 (2013).
64. Wang, Q., Garrity, G.M., Tiedje, J.M. & Cole, J.R. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 73, 5261-5267 (2007).
65. Cole, J.R. et al. Ribosomal Database Project: data and tools for high throughput rRNA analysis. Nucleic Acids Res. 42, D633-D642 (2014).
66. Yarza, P. et al. The All-Species Living Tree project: A 16S rRNA-based phylogenetic tree of all sequenced type strains. Syst. Appl. Microbiol. 31, 241-250 (2008).
67. Schloss, P.D. et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl. Environ. Microbiol. 75, 7537-7541 (2009).
68. Oksanen, J. et al. vegan: Community Ecology Package http://CRAN.R-project.org/package=vegan (2013).
69. Livak, K.J. & Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔCT) method. Methods 25, 402-408 (2001).